Neoplasms: all 9,617 studies

Page 63 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• Study of BAY1834942 in Patients With Solid TumorsCompletedNCT03596372Phase 1
• A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsCompletedNCT03595059Phase 1
• Prospective Thinking in Hormone-Responsive Breast CancerCompletedNCT03594578Not applicable
• Validation of an Oncology-specific Instrument to Measure Care CoordinationCompletedNCT03594006Not applicable
• Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced CancerWithdrawnNCT03592459Not applicable
• Improving Cancer Patients' Insurance ChoicesCompletedNCT03592433Not applicable
• A Study of Anlotinib in Recurrent/Metastatic Head and Neck AdenocarcinomasStatus unknownNCT03591666Phase 2
• Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple MyelomaTerminatedNCT03590652Phase 2
• Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesCompletedNCT03590054Phase 1
• INCMGA00012 in Combination With Other Therapies in Patients With Advanced Solid TumorsCompletedNCT03589651Phase 1
• A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid TumorsCompletedNCT03588650Phase 1
• Study of EOC317 in Chinese Patients With Advanced Solid TumorsStatus unknownNCT03583125Phase 1
• The Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer SubjectsTerminatedNCT03582280Phase 1
• The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.CompletedNCT03577704Phase 1/2
• Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell CancerCompletedNCT03575949Not applicable
• A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSCompletedNCT03573310Phase 1
• Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback StrategiesCompletedNCT03569605Not applicable
• Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful ProceduresSuspendedNCT03568292Not applicable
• PET Avidity in Cachexia-Inducing Lung and Gastrointestinal TumorsActive, not recruitingNCT03568019
• CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative NeoplasmsCompletedNCT03566446Phase 1
• Stress Management and Resilience Training (SMART) Intervention for Family Caregivers of Individuals With Advanced CancerCompletedNCT03565757Not applicable
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid TumorsCompletedNCT03565445Phase 1
• Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001)CompletedNCT03564691Phase 1
• Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)Status unknownNCT03563326Phase 1
• Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCompletedNCT03562897Phase 2
• Risk Factors for Development of Incisional Hernia in Transverse IncisionsStatus unknownNCT03561727Not applicable
• A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type MalignanciesActive, not recruitingNCT03560882Phase 1
• Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaCompletedNCT03559543Phase 2
• CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell MalignanciesStatus unknownNCT03559439Phase 1
• The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative NeoplasmStatus unknownNCT03558607Phase 1/2
• WB-EMS and Nutrition in Patients With Hematological MalignanciesStatus unknownNCT03556748Not applicable
• A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
• Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]CompletedNCT03555422Phase 3
• Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK CellsStatus unknownNCT03554889Phase 1
• A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.CompletedNCT03553108Phase 1
• Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid TumorsStatus unknownNCT03552406Phase 1
• Influence of Motor Proteins on Muscle Atrophy in Cancer PatientsStatus unknownNCT03551990Not applicable
• Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid TumorCompletedNCT03551795Phase 1/2
• Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionCompletedNCT03549494Phase 2
• POWERPLAY: Promoting Men's Health at WorkCompletedNCT03548077Not applicable
• A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.CompletedNCT03545971Phase 1
• Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.Status unknownNCT03545815Phase 1
• Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Status unknownNCT03544723Phase 2
• Diaphragmatic Resection And Gynecological Ovarian NeoplasmCompletedNCT03543462Phase 4
• First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)CompletedNCT03542513
• Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal StenosisTerminatedNCT03540953Not applicable
• Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerActive, not recruitingNCT03539536Phase 2
• Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector CellsTerminatedNCT03535246Phase 1/2
• Extra Layer Of SupportCompletedNCT03532997Not applicable
• Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)CompletedNCT03532347Not applicable
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple MyelomaTerminatedNCT03530683Phase 1
• A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsActive, not recruitingNCT03530397Phase 1
• Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)CompletedNCT03530215
• Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid TumorsStatus unknownNCT03529526Phase 1
• Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer PatientsCompletedNCT03525990Not applicable
• ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid TumorsCompletedNCT03525795Phase 1
• Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLCStatus unknownNCT03525782Phase 1/2
• A Study of CS1002 in Subjects with Advanced Solid TumorsCompletedNCT03523819Phase 1
• Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral BronchoscopyCompletedNCT03523689
• Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATSStatus unknownNCT03521986Phase 3
• Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid TumorsCompletedNCT03517956Phase 1
• A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid TumorsCompletedNCT03516123Phase 1
• A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine NeoplasmsStatus unknownNCT03511768Phase 1/2
• Selective Rather Than Routine Histopathological Examination Following Appendectomy and CholecystectomyCompletedNCT03510923
• Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid TumorsCompletedNCT03510104Phase 1
• Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
• Benefit Evaluation of Foot Reflexology in OncologyCompletedNCT03508180Not applicable
• Combined Immunotherapy and Radiosurgery for Metastatic Colorectal CancerCompletedNCT03507699Phase 1
• Evaluation of the Metastasis and Recurrence of Prostate CancerStatus unknownNCT03507595
• A Study of Zolbetuximab (IMAB362) in Adults With Gastric CancerActive, not recruitingNCT03505320Phase 2
• The Diagnostic Value of Combinatory EUS and ERCP in Unclear LesionsCompletedNCT03504293
• TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid NeoplasmsTerminatedNCT03503968Phase 1/2
• A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid TumorsStatus unknownNCT03503604Phase 1
• What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?Status unknownNCT03501394Not applicable
• Solid Tumor Imaging MR-Linac (STIM Study)SuspendedNCT03500081
• A Study of Rucaparib in Japanese Patients With a Previously-treated Solid TumorCompletedNCT03499444Phase 1
• Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial TissueCompletedNCT03498924
• Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on CytologyCompletedNCT03498183Phase 2/3
• Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid TumorsWithdrawnNCT03496519Phase 1
• A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor Receptor-2 in Patients With Advanced Solid TumorsTerminatedNCT03494231Phase 1
• Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid TumorsStatus unknownNCT03491631Phase 1
• K-Basket, Avelumab, Biomarker-driven, Advanced Solid TumorStatus unknownNCT03491345Phase 2
• 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate CancerTerminatedNCT03490838Phase 1
• Visualase Visualization Database (VIVID-1)CompletedNCT03489187
• Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701)Status unknownNCT03488446
• BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With PembrolizumabCompletedNCT03486301Phase 1
• Hyperspectral Imaging for Neoplasm Early Stage DetectionStatus unknownNCT03483974
• Measuring Health Related Quality of Life in AYAsCompletedNCT03482778
• Psychological Services Integration in Gynecological Oncology ClinicsCompletedNCT03481127Phase 1
• Liquid Biopsy in Lung CancerCompletedNCT03479099
• Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT03478995Phase 1
• Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerCompletedNCT03477019Phase 1/2
• An Observational Prospective Cohort Study Using an Actigraphy Device.CompletedNCT03475433
• Copanlisib and Rituximab in Marginal Zone Lymphoma PatientsActive, not recruitingNCT03474744Phase 2
• Safety and Efficacy of an Anticancer Medication Combined With Immune Cells in Subjects With Solid TumorsStatus unknownNCT03472352Phase 1
• Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced RashCompletedNCT03471364Early Phase 1
• A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor MalignanciesTerminatedNCT03471286Phase 1
• Nomogram Control of Predictive Factors of Early Withdrawal After Gynecologic Oncology Surgery in the Enhanced Recovery After Surgery (ERAS) Protocol and Assessment of PracticesStatus unknownNCT03470870
• Oxidoreductive Balance and Lysosomal Activity in Cancer Patients.CompletedNCT03470857
• Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid TumorsStatus unknownNCT03468751Phase 1

← Neoplasms overview